HBM Healthcare Investments Shareholders' Meeting Approves Board Proposals

During the recent Shareholders' Meeting of HBM Healthcare Investments Ltd, all board proposals were approved by shareholders. Chairman Hans Peter Hasler, along with board members Dr. Rudolf Lanz, Mario G. Giuliani, Dr. Stella X. Xu, and Dr. Elaine V. Jones, were re-elected for another one-year term. The Compensation Committee members also retained their positions.

A significant decision was the reduction in share capital via the cancellation of 220,000 registered treasury shares acquired in a buyback program. Shareholders will receive a par value repayment of CHF 2.60 per share and a dividend of CHF 4.90 per share, payable on July 4, 2025. The shares will trade without entitlement from July 2, 2025.

Additionally, a new share buyback program was approved, targeting up to 10% of outstanding shares over three years for capital reduction purposes.